Login to Your Account



Drug prices at heart of generics guidances, FDA workshop

By Mari Serebrov
Regulatory Editor

Monday, October 2, 2017

Making good on Commissioner Scott Gottlieb's promise to tackle high drug prices by streamlining the path for generics, the FDA issued new guidance on developing generics of complex drugs and opened a two-day workshop Monday on ways to modernize the development and review of generic drugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription